Document is current
Any future updates will be listed below
-
Authors
Teschendorff, Andrew E. https://orcid.org/0000-0001-7410-6527
Horvath, Steve https://orcid.org/0000-0002-4110-3589
- License Information
-
More Information
Article History
Accepted: 20 November 2024
First Online: 13 January 2025
Competing interests
: S.H. and his team developed the first epigenetic clocks for human saliva, for all tissues (pan-tissue clock), for human mortality risk prediction (PhenoAge, GrimAge), and pan-mammalian clocks. The Regents of the University of California are the sole owner of patents and patent applications directed at epigenetic biomarkers for which S.H. is a named inventor; S.H. is a founder and paid consultant of the non-profit Epigenetic Clock Development Foundation that licenses these patents. S.H. is a principal investigator at the Altos Labs, Cambridge Institute of Science, a biomedical company that works on biological rejuvenation. A.E.T. declares no competing interests.
